Pds Biotechnology Corp Stock Analysis

PDS Stock Analysis Notes

About 16.0% of the company shares are owned by institutional investors. The book value of PDS Biotechnology was at this time reported as 0.5. The company recorded a loss per share of 0.91. PDS Biotechnology Corp last dividend was issued on the 18th of March 2019. The entity had 1:20 split on the 18th of March 2019. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. Pds Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. To find out more about PDS Biotechnology Corp contact Frank BeduAddo at 800 208 3343 or learn more at https://www.pdsbiotech.com.

PDS Biotechnology Corp Investment Alerts

PDS Biotechnology Corp Upcoming and Recent Events

PDS Largest EPS Surprises

View All Earnings Estimates

PDS Biotechnology Thematic Classifications

PDS Stock Institutional Investors

Note, although PDS Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PDS Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.99 M.

PDS Profitablity

Management Efficiency

PDS Biotechnology Corp has return on total asset (ROA) of (0.4242) % which means that it has lost $0.4242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5616) %, meaning that it created substantial loss on money invested by shareholders. PDS Biotechnology's management efficiency ratios could be used to measure how well PDS Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. As of November 15, 2025, Return On Tangible Assets is expected to decline to -0.87. In addition to that, Return On Capital Employed is expected to decline to -1.35. At present, PDS Biotechnology's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 319.1 M, whereas Non Current Assets Total are forecasted to decline to about 289 K.

Technical Drivers

As of the 15th of November 2025, PDS Biotechnology holds the Market Risk Adjusted Performance of (0.33), risk adjusted performance of (0.07), and Coefficient Of Variation of (875.74). Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of PDS Biotechnology, as well as the relationship between them.

PDS Biotechnology Corp Price Movement Analysis

PDS Biotechnology Corp Insider Trading Activities

PDS Biotechnology Outstanding Bonds

PDS Biotechnology Predictive Daily Indicators

PDS Biotechnology Forecast Models

PDS Biotechnology's time-series forecasting models are one of many PDS Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PDS Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how PDS Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PDS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PDS Biotechnology. By using and applying PDS Stock analysis, traders can create a robust methodology for identifying PDS entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PDS analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PDS analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

PDS Biotechnology Corp stock analysis indicators help investors evaluate how PDS Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading PDS Biotechnology shares will generate the highest return on investment. By understating and applying PDS Biotechnology stock analysis, traders can identify PDS Biotechnology position entry and exit signals to maximize returns.

When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.